PortfoliosLab logoPortfoliosLab logo
KEEL vs. SKYE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KEEL vs. SKYE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Keel Infrastructure Corporation (KEEL) and Skye Bioscience, Inc (SKYE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KEEL achieves a 84.68% return, which is significantly higher than SKYE's -12.81% return.


KEEL

1D
9.87%
1M
-31.00%
6M
47.12%
YTD
84.68%
1Y
317.31%
3Y*
35.62%
5Y*
5.25%
10Y*
ALL TIME*
14.60%

SKYE

1D
0.68%
1M
-7.58%
6M
-34.63%
YTD
-12.81%
1Y
-83.20%
3Y*
-54.08%
5Y*
-55.74%
10Y*
-40.13%
ALL TIME*
-48.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KEEL vs. SKYE - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KEEL
Keel Infrastructure Corporation
84.68%57.72%-48.80%561.36%-91.29%165.79%397.66%-27.96%-64.19%
SKYE
Skye Bioscience, Inc
-12.81%-73.51%4.04%-32.84%-68.85%30.00%-69.47%-67.25%74.67%

Correlation

The correlation between KEEL and SKYE is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Aug 28, 2018

0.04

The correlation between KEEL and SKYE shifts across timeframes, from 0.04 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KEEL:

$2.62B

SKYE:

$22.97M

EPS

KEEL:

-$0.51

SKYE:

-$1.45

PB Ratio

KEEL:

4.27

SKYE:

2.88

Total Revenue (TTM)

KEEL:

$229.28M

SKYE:

$0.00

Gross Profit (TTM)

KEEL:

-$18.90M

SKYE:

-$180.01K

EBITDA (TTM)

KEEL:

-$149.60M

SKYE:

$10.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KEEL vs. SKYE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEEL
KEEL Risk / Return Rank: 9292
Overall Rank
KEEL Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
KEEL Sortino Ratio Rank: 9393
Sortino Ratio Rank
KEEL Omega Ratio Rank: 9090
Omega Ratio Rank
KEEL Calmar Ratio Rank: 9393
Calmar Ratio Rank
KEEL Martin Ratio Rank: 8686
Martin Ratio Rank

SKYE
SKYE Risk / Return Rank: 1010
Overall Rank
SKYE Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
SKYE Sortino Ratio Rank: 99
Sortino Ratio Rank
SKYE Omega Ratio Rank: 88
Omega Ratio Rank
SKYE Calmar Ratio Rank: 55
Calmar Ratio Rank
SKYE Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KEEL vs. SKYE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Keel Infrastructure Corporation (KEEL) and Skye Bioscience, Inc (SKYE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KEELSKYEDifference
Sharpe ratioReturn per unit of total volatility

+3.68

Sortino ratioReturn per unit of downside risk

+4.48

Omega ratioGain probability vs. loss probability

1.37

0.82

+0.55

Calmar ratioReturn relative to maximum drawdown

4.34

-0.95

+5.29

Martin ratioReturn relative to average drawdown

7.13

-1.17

+8.29

KEEL vs. SKYE - Sharpe Ratio Comparison

The current KEEL Sharpe Ratio is 2.88, which is higher than the SKYE Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of KEEL and SKYE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KEEL vs. SKYE - Drawdown Comparison

The maximum KEEL drawdown since its inception was -95.72%, roughly equal to the maximum SKYE drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for KEEL and SKYE.


Loading charts...

Drawdown Indicators


KEELSKYEDifference

Max Drawdown

Largest peak-to-trough decline

-95.72%

-99.96%

+4.24%

Max Drawdown (1Y)

Largest decline over 1 year

-73.65%

-87.85%

+14.20%

Max Drawdown (3Y)

Largest decline over 3 years

-81.04%

-96.79%

+15.75%

Max Drawdown (5Y)

Largest decline over 5 years

-95.72%

-98.56%

+2.84%

Max Drawdown (10Y)

Largest decline over 10 years

-99.83%

Current Drawdown

Current decline from peak

-51.07%

-99.95%

+48.88%

Average Drawdown

Average peak-to-trough decline

-67.17%

-94.97%

+27.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

44.75%

71.33%

-26.58%

Volatility

KEEL vs. SKYE - Volatility Comparison

Keel Infrastructure Corporation (KEEL) has a higher volatility of 29.29% compared to Skye Bioscience, Inc (SKYE) at 13.30%. This indicates that KEEL's price experiences larger fluctuations and is considered to be riskier than SKYE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KEELSKYEDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.29%

13.30%

+15.99%

Volatility (6M)

Calculated over the trailing 6-month period

71.73%

54.45%

+17.28%

Volatility (1Y)

Calculated over the trailing 1-year period

111.13%

104.19%

+6.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

105.29%

130.62%

-25.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

289.41%

136.40%

+153.01%

Dividends

KEEL vs. SKYE - Dividend Comparison

Neither KEEL nor SKYE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KEEL vs. SKYE - Financials Comparison

This section allows you to compare key financial metrics between Keel Infrastructure Corporation and Skye Bioscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
15.38M
0
(KEEL) Total Revenue
(SKYE) Total Revenue
Values in USD except per share items

Frequently Asked Questions


KEEL and SKYE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KEEL has higher volatility (29.29%) compared to SKYE (13.30%). In terms of maximum drawdown, KEEL dropped -95.72% vs SKYE's -99.96%.

KEEL currently has the higher Sharpe Ratio (2.88 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KEEL and SKYE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer